🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This Phase Ib/II, open-label, multicenter trial is designed to evaluate the...
Status
Terminated
Location
Multiple Locations
Start Date
2006-06
Trial ID
NCT00400764
Treatments Being Tested
Prospective, double-blind, randomized assessment of the efficacy, safety an...
Status
Completed
Location
Research Site 1
Start Date
2017-03-29
Trial ID
NCT03027609
Background: X-Linked Chronic Granulomatous Disease (X-CGD) is caused by a ...
Status
Enrolling By Invitation
Location
National Institutes of Health Clinical Center
Start Date
2025-09-10
Trial ID
NCT07113743
This study is designed as a multicenter, randomized, double-blind, placebo-...
Status
Unknown
Location
Shanghai Public Health Clinical Center
Start Date
2020-12-29
Trial ID
NCT04627584
Treatments Being Tested
GSK3359609 is an anti-Inducible T cell Co-Stimulator (ICOS) receptor agonis...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-06-23
Trial ID
NCT02723955
This first-in-human study will evaluate the recommended dose for further cl...
Status
Terminated
Location
Sarah Cannon Research Institute - TN Oncology
Start Date
2020-06-19
Trial ID
NCT04441099
Treatments Being Tested
This is a first-in-human, open-label, multi-center, Phase 1, dose-escalatio...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2024-05-01
Trial ID
NCT06299163
Treatments Being Tested
This is a 2-cohort (observational and treatment cohort) extension study for...
Status
Terminated
Location
Site Number - 1520
Start Date
2022-11-06
Trial ID
NCT05517447
Treatments Being Tested
Unresectable metastatic colorectal cancer (mCRC) remains an incurable disea...
Status
Active Not Recruiting
Location
Centre Georges-François Leclerc
Start Date
2022-10-13
Trial ID
NCT05201352
Treatments Being Tested
This phase I/II trial studies the best dose and side effects of mogamulizum...
Status
Completed
Location
University of California Davis Comprehensive Cancer Center
Start Date
2018-10-24
Trial ID
NCT03309878
Treatments Being Tested